Osteoprogenitor Cells from Bone Marrow and Cortical Bone: Understanding How the Environment Affects Their Fate

Stem Cells and Development

Volumn 24, Issue 9, 2015, Pages 1112-1123

  Corradetti, Bruna ^a,b   Taraballi, Francesca ^a,c   Powell, Sebastian ^a   Sung, David ^a   Minardi, Silvia ^a,d   Ferrari, Mauro ^a   Weiner, Bradley K ^a,e   Tasciotti, Ennio ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

^e HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CLONOGENESIS; CORTICAL BONE; CORTICAL BONE FRAGMENT MESENCHYMAL STEM CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BONE; BONE MARROW CELL; CELL CULTURE; CELL LINEAGE; CYTOLOGY; ENVIRONMENT; GENETICS; METABOLISM; OSTEOBLAST; SPRAGUE DAWLEY RAT;

CYTOKINE; LEUKOCYTE ANTIGEN;

ANIMALS; ANTIGENS, CD; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CYTOKINES; ENVIRONMENT; OSTEOBLASTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84930793705     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0351     Document Type: Article

References (72)

1. Bianco P, PG Robey and PJ Simmons. (2008). Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313-319.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
3. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for cellular therapy position statement. Cytotherapy 8:315-317.
4. Caplan AI. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347.
5. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
6. Ren G, L Zhang, X Zhao, G Xu, Y Zhang, AI Roberts, RC Zhao and Y Shi. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141-150.
7. Chamberlain G, J Fox, B Ashton and J Middleton. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749.
8. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
9. Fraser JK, I Wulur, Z Alfonso and MH Hedrick. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24:150-154.
10. Villaron EM, J Almeida, N Lopez-Holgado, M Alcoceba, LI Sanchez-Abarca, FM Sanchez-Guijo, M Alberca, JA Perez-Simon, JF San Miguel and MC Del Canizo. (2004). Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 89:1421-1427.
11. Griffiths MJ, D Bonnet and SM Janes. (2005). Stem cells of the alveolar epithelium. Lancet 366:249-260.
12. Beltrami AP, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
13. Lovati AB, B Corradetti, A Lange Consiglio, C Recordati, E Bonacina, D Bizzaro and F Cremonesi. (2011). Characterization and differentiation of equine tendon-derived progenitor cells. J Biol Regul Homeost Agents 25(2 Suppl):S75-S84.
14. Huang TF, YT Chen, TH Yang, LL Chen, SH Chiou, TH Tsai, CC Tsai, MH Chen, HL Ma and SC Hung. (2008). Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament. Cytotherapy 10:806-814.
15. Soncini M, E Vertua, L Gibelli, F Zorzi, M Denegri, A Albertini, GS Wengler and O Parolini. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305.
16. Corradetti B, A Meucci, D Bizzaro, F Cremonesi and A Lange Consiglio. (2013). Mesenchymal stem cells from amnion and amniotic fluid in the bovine. Reproduction 145:391-400.
17. Lange-Consiglio A, B Corradetti, D Bizzaro, M Magatti, L Ressel, S Tassan, O Parolini and F Cremonesi. (2012). Characterization and potential applications of progenitorlike cells isolated from horse amniotic membrane. J Tissue Eng Regen Med 6:622-635.
18. Lange-Consiglio A, V Maggio, L Pellegrino and F Cremonesi. (2012). Equine bone marrow mesenchymal or amniotic epithelial stem cells as feeder in a model for the in vitro culture of bovine embryos. Zygote 20:45-51.
19. Sarugaser R, D Lickorish, D Baksh, MM Hosseini and JE Davies. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23:220-229.
20. WeissML, SMedicetty,ARBledsoe,RSRachakatla,MChoi, S Merchav, Y Luo, MS Rao, G Velagaleti and D Troyer. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodentmodel of Parkinson's disease. Stem Cells 24:781-792.
21. Corradetti B, A Lange-Consiglio, M Barucca, F Cremonesi and D Bizzaro. (2011). Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix. Cell Prolif 44:330-342.
22. Liechty KW, TC MacKenzie, AF Shaaban, A Radu, AM Moseley, R Deans, DR Marshak and AW Flake. (2000). Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282-1286.
23. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
24. Patel DM, J Shah and AS Srivastava. (2013). Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int 2013:Article ID 496218.
25. Murphy MB, K Moncivais and AI Caplan. (2013). Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 45:e54.
26. Casiraghi F, M Noris and G Remuzzi. (2010). Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant 15:731-737.
27. Hass R, C Kasper, S Bohm and R Jacobs. (2011). Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12.
28. Ivanova NB, JT Dimos, C Schaniel, JA Hackney, KA Moore and IR Lemischka. (2002). A stem cell molecular signature. Science 298:601-604.
29. Ramalho-Santos M, S Yoon, Y Matsuzaki, RC Mulligan and DA Melton. (2002). "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298:597-600.
30. Yagi H, A Soto-Gutierrez, B Parekkadan, Y Kitagawa, RG Tompkins, N Kobayashi and ML Yarmush. (2010). Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19:667-679.
31. Li B, C Moshfegh, Z Lin, J Albuschies and V Vogel. (2013). Mesenchymal stem cells exploit extracellular matrix as mechanotransducer. Sci R 3:2425.
32. Watt FM and BL Hogan. (2000). Out of Eden: stem cells and their niches. Science 287:1427-1430.
33. Spradling A, D Drummond-Barbosa and T Kai. (2001). Stem cells find their niche. Nature 414:98-104.
34. Jones DL and AJ Wagers. (2008). No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 9:11-21.
35. Fuchs E, T Tumbar and G Guasch. (2004). Socializing with the neighbors: stem cells and their niche. Cell 116:769-778.
36. Honczarenko M, Y Le, M Swierkowski, I Ghiran, AM Glodek and LE Silberstein. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041.
37. Krampera M, L Cosmi, R Angeli, A Pasini, F Liotta, A Andreini, V Santarlasci, B Mazzinghi, G Pizzolo, et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398.
38. Sakaguchi Y, I Sekiya, K Yagishita, S Ichinose, K Shinomiya and T Muneta. (2004). Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 104:2728-2735.
39. Sottile V, C Halleux, F Bassilana, H Keller and K Seuwen. (2002). Stem cell characteristics of human trabecular bonederived cells. Bone 30:699-704.
40. Tuli R, MR Seghatoleslami, S Tuli, ML Wang, WJ Hozack, PA Manner, KG Danielson and RS Tuan. (2003). A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol 23:37-49.
41. Tuli R, S Tuli, S Nandi, ML Wang, PG Alexander, H Haleem-Smith, WJ Hozack, PA Manner, KG Danielson and RS Tuan. (2003). Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21:681-693.
42. Zhu H, ZK Guo, XX Jiang, H Li, XY Wang, HY Yao, Y Zhang and N Mao. (2010). A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 5:550-560.
43. Bianco P. (2011). Minireview: the stem cell next door: skeletal and hematopoietic stem cell "niches" in bone. Endocrinology 152:2957-2962.
44. Hattner R, BN Epker and HM Frost. (1965). Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206:489-490.
45. Takayanagi H. (2007). Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292-304.
46. Negishi-Koga T and H Takayanagi. (2012). Bone cell communication factors and Semaphorins. BoneKEy Rep 1183.
47. Calvi LM, GB Adams, KW Weibrecht, JM Weber, DP Olson, MC Knight, RP Martin, E Schipani, P Divieti, et al. (2003). Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846.
48. Yin T and L Li. (2006). The stem cell niches in bone. J Clin Invest 116:1195-1201.
49. Soleimani M and S Nadri. (2009). A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4:102-106.
50. Hegyi B, G Kudlik, E Monostori and F Uher. (2012). Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells. Biochem Biophys Res Commun 419:215-220.
51. Roubelakis MG, KI Pappa, V Bitsika, D Zagoura, A Vlahou, HA Papadaki, A Antsaklis and NP Anagnou. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16:931-952.
52. Foudah D, J Redondo, C Caldara, F Carini, G Tredici and M Miloso. (2012). Expression of neural markers by undifferentiated rat mesenchymal stem cells. J Biomed Biotechnol 2012:820821.
53. Mendez-Ferrer S, TV Michurina, F Ferraro, AR Mazloom, BD Macarthur, SA Lira, DT Scadden, A Ma'ayan, GN Enikolopov and PS Frenette. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834.
54. Ehninger A and A Trumpp. (2011). The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208:421-428.
55. Thomson TM, WJ Rettig, PG Chesa, SH Green, AC Mena and LJ Old. (1988). Expression of human nerve growth factor receptor on cells derived from all three germ layers. Exp Cell Res 174:533-539.
56. Lee CC, JE Christensen, MC Yoder and AF Tarantal. (2010). Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp Hematol 38:46-54.
57. Jones EA, A English, SE Kinsey, L Straszynski, P Emery, F Ponchel and D McGonagle. (2006). Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 70:391-399.
58. Quirici N, D Soligo, P Bossolasco, F Servida, C Lumini and GL Deliliers. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783-791.
59. Meyerrose TE, DA De Ugarte, AA Hofling, PE Herrbrich, TD Cordonnier, LD Shultz, JC Eagon, L Wirthlin, MS Sands, MA Hedrick and JA Nolta. (2007). In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25:220-227.
60. Weiss ML and DL Troyer. (2006). Stem cells in the umbilical cord. Stem Cell Rev 2:155-162.
61. Bentivegna A, M Miloso, G Riva, D Foudah, V Butta, L Dalpra and G Tredici. (2013). DNA methylation changes during in vitro propagation of human mesenchymal stem cells: implications for their genomic stability? Stem Cells Int 2013:192425.
62. Wiesmann A, HJ Buhring, C Mentrup and HP Wiesmann. (2006). Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation. Head Face Med 2:28.
63. Hayer S, G Steiner, B Gortz, E Reiter, M Tohidast-Akrad, M Amling, O Hoffmann, K Redlich, J Zwerina, et al. (2005). CD44 is a determinant of inflammatory bone loss. J Exp Med 201:903-914.
64. Takedachi M, H Oohara, BJ Smith, M Iyama, M Kobashi, K Maeda, CL Long, MB Humphrey, BJ Stoecker, et al. (2012). CD73-generated adenosine promotes osteoblast differentiation. J Cell Physiol 227:2622-2631.
65. Redaelli S, A Bentivegna, D Foudah, M Miloso, J Redondo, G Riva, S Baronchelli, L Dalpra and G Tredici. (2012). From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 3:47.
66. Hughes FJ, LD Buttery, MV Hukkanen, A O'Donnell, J Maclouf and JM Polak. (1999). Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274:1776-1782.
67. Zinocker S and JT Vaage. (2012). Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase. Front Immunol 3:62.
68. Zinocker S, MY Wang, B Rolstad and JT Vaage. (2012). Mesenchymal stromal cells fail to alleviate experimental graft-versus-host disease in rats transplanted with major histocompatibility complex-mismatched bone marrow. Scand J Immunol 76:464-470.
69. Klein-Nulend J, RF van Oers, AD Bakker and RG Bacabac. (2013). Nitric oxide signaling in mechanical adaptation of bone. Osteoporos Int 25:1427-1437.
70. Burnstock G and TR Arnett. (2007). Nucleotides and Regulation of Bone Cell Function. CRC/Taylor & Francis, Boca Raton, FL, p. 207.
71. Keila S, A Kelner and M Weinreb. (2001). Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol 168:131-139.
72. Kuci S, Z Kuci, H Kreyenberg, E Deak, K Putsch, S Huenecke, C Amara, S Koller, E Rettinger, et al. (2010). CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftmentpromoting properties. Haematologica 95:651-659.